1. Home
  2. ANIP vs WT Comparison

ANIP vs WT Comparison

Compare ANIP & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANIP

ANI Pharmaceuticals Inc.

N/A

Current Price

$76.28

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo WisdomTree Inc.

WT

WisdomTree Inc.

N/A

Current Price

$15.66

Market Cap

2.4B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ANIP
WT
Founded
2001
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.4B
IPO Year
1999
2011

Fundamental Metrics

Financial Performance
Metric
ANIP
WT
Price
$76.28
$15.66
Analyst Decision
Strong Buy
Hold
Analyst Count
6
3
Target Price
$107.33
$17.08
AVG Volume (30 Days)
298.2K
2.2M
Earning Date
05-11-2026
05-01-2026
Dividend Yield
N/A
0.73%
EPS Growth
419.23
127.27
EPS
3.32
0.75
Revenue
$206,547,000.00
$493,753,000.00
Revenue This Year
$19.88
$33.08
Revenue Next Year
$15.77
$7.39
P/E Ratio
$22.90
$21.80
Revenue Growth
2.47
15.43
52 Week Low
$56.71
$7.47
52 Week High
$99.50
$17.68

Technical Indicators

Market Signals
Indicator
ANIP
WT
Relative Strength Index (RSI) 46.83 42.23
Support Level $75.20 $15.38
Resistance Level $84.47 $17.09
Average True Range (ATR) 2.44 0.59
MACD 0.15 -0.22
Stochastic Oscillator 61.39 8.86

Price Performance

Historical Comparison
ANIP
WT

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About WT WisdomTree Inc.

WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.

Share on Social Networks: